- Report
- January 2025
- 305 Pages
Global
From €4474EUR$5,000USD£3,872GBP
- Report
- June 2025
- 150 Pages
Global
From €3445EUR$3,850USD£2,982GBP
- Report
- April 2025
- 150 Pages
Global
From €2908EUR$3,250USD£2,517GBP
€4340EUR$4,850USD£3,756GBP
- Report
- March 2025
- 150 Pages
Global
From €2908EUR$3,250USD£2,517GBP
€4340EUR$4,850USD£3,756GBP
- Report
- December 2024
- 150 Pages
Global
From €2908EUR$3,250USD£2,517GBP
€4340EUR$4,850USD£3,756GBP
- Report
- November 2024
- 150 Pages
Global
From €2908EUR$3,250USD£2,517GBP
€4340EUR$4,850USD£3,756GBP
- Report
- September 2024
- 150 Pages
Global
From €2908EUR$3,250USD£2,517GBP
€4340EUR$4,850USD£3,756GBP
- Report
- July 2025
- 281 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 274 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 284 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 182 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 370 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 190 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 474 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 492 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 379 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 590 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 586 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 474 Pages
Global
From €5234EUR$5,850USD£4,531GBP
- Report
- July 2025
- 378 Pages
Global
From €5234EUR$5,850USD£4,531GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more